Friday, February 12, 2021

Covid-19 drugs among top-selling brands for pharma players in India

Data shows that cumulative sales of remdesivir was Rs 510 crore in January 2021, while for favipiravir it was Rs 471 crore

from Today's Paper https://ift.tt/3rK84WT
via

No comments:

Post a Comment

If you have any doubts please let me know!

India's low score on GVC a starting point for recovery from pandemic: AIIB

India rated 7.4 percentage points below the average global value chain participation rate for emerging economies from Today's Paper ht...